Circadian Clock Found To Regulate Platelet Function
9/12/2011
Researchers at Brigham and Women's Hospital (BWH) have demonstrated that the circadian system, the body's internal clock, regulates human platelet function and causes a peak in platelet activation corresponding to the known morning peak in adverse cardiovascular events. These findings are published in PLoS ONE...
Lower Quality Of Lung Cancer Care Delivered By Hospitals Of Last Resort
9/12/2011
A new study finds that lung cancer patients treated in hospitals that care for a high percentage of uninsured and Medicaid-insured patients, so-called "high safety-net burden facilities," were significantly less likely to undergo surgery that was intended to cure the cancer compared to patients treated at low safety-net burden facilities...
Evaluating The Effectiveness Of Decreased Doses Of Cervical Cancer Vaccine
9/12/2011
Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published September 9 in the Journal of the National Cancer Institute...
Smart Bomb Destroys Solid Cancers And Ignores Healthy Tissue
9/12/2011
ICT2588 is a compound that can probably destroy all forms of solid tumors while leaving healthy tissue unharmed, researchers from the University of Bradford, England, have explained. Professor Laurence Patterson, head of the research team, said the "SMART bomb" could be used in human trials within the next two years, perhaps even in just 18 months' time. ICT2588 is derived from the autumn crocus...
Lifting Lifetime Ban On Gay Men From Donating Blood Welcomed By HIV Charities, UK
9/11/2011
Following a review of current policies by the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) regarding the exclusion and deferral from blood donation, the UK Government announced that it will change its policies to allow gay men to donate blood after a 12 months deferral period. So far gay men had not been allowed to donate blood...
Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have made a landmark discovery in the battle against the rapid spread of aggressive cancers associated with PRL-3 oncoprotein[1]...
Lifetime Ban On Gay Men From Donating Blood Welcomed By HIV Charities, UK
9/11/2011
Following a review of current policies by the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) regarding the exclusion and deferral from blood donation, the UK Government announced that it will change its policies to allow gay men to donate blood after a 12 months deferral period. So far gay men had not been allowed to donate blood...
Tarceva (erlotinib) Good Alternative To Chemotherapy For Some Lung Cancer Patients, UK
9/11/2011
According to today's announcement by Roche, Tarceva (erlotinib), an oral lung cancer treatment, has been officially licensed as first-line monotherapy for the treatment of patients with advanced forms of non-small cell lung cancer (NSCLC) with a certain mutation, saving them from up-front chemotherapy...
Protalix BioTherapeutics, Inc. (NYSE-AMEX: PLX, TASE: PLX), announced that an article entitled "Pivotal Trial with Plant-Cell-Expressed Recombinant Glucocerebrosidase, taliglucerase alfa, a Novel Enzyme Replacement Therapy for Gaucher Disease" has been published in Blood, the Journal of the American Society of Hematology...
Nektar Therapeutics (Nasdaq: NKTR) announced that positive results from the company's Phase 2 clinical study of NKTR-102 in patients with metastatic breast cancer were presented at the ASCO 2011 Breast Cancer Symposium in San Francisco, California...